REGENXBIO Inc. (RGNX) Operating Income (Loss) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
REGENXBIO Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • REGENXBIO Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$63.9 M, a 3.47% increase year-over-year.
  • REGENXBIO Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$266 M, a 3.23% decline year-over-year.
  • REGENXBIO Inc. annual Operating Income (Loss) for 2023 was -$268 M, a 2% decline from 2022.
  • REGENXBIO Inc. annual Operating Income (Loss) for 2022 was -$263 M, a 264% decline from 2021.
  • REGENXBIO Inc. annual Operating Income (Loss) for 2021 was $160 M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$266 M -$63.9 M +$2.29 M +3.47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$268 M -$63.9 M -$6.13 M -10.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$262 M -$65 M +$6.09 M +8.57% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$268 M -$73.1 M -$10.6 M -16.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$258 M -$66.2 M +$5.37 M +7.51% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$263 M -$57.8 M -$371 M -118% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $108 M -$71 M -$13.7 M -23.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $122 M -$62.5 M -$10.3 M -19.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $132 M -$71.5 M -$27.5 M -62.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $160 M $314 M +$367 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$207 M -$57.3 M -$71.3 M -511% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$136 M -$52.2 M -$10.4 M -24.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$126 M -$44 M -$6.34 M -16.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$119 M -$53.7 M -$13.3 M -33.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$106 M $14 M +$49.8 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$156 M -$41.8 M -$4.96 M -13.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$151 M -$37.7 M -$1.79 M -5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$149 M -$40.3 M -$42.8 M -1746% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$106 M -$35.9 M -$13.2 M -58% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$93.1 M -$36.9 M -$43.2 M -681% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$49.8 M -$35.9 M -$138 M -135% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $88.1 M $2.45 M +$19 M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $69.1 M -$22.7 M -$1.42 M -6.65% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $70.5 M $6.35 M +$21.4 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $49.1 M $102 M +$125 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$75.9 M -$16.6 M +$3.87 M +18.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 -$79.8 M -$21.3 M -$2.64 M -14.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$77.1 M -$15.1 M -$104 K -0.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$77 M -$22.9 M -$11.7 M -104% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$65.3 M -$20.5 M -$15 M -272% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$50.4 M -$18.7 M -$11.3 M -154% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$39.1 M -$15 M -$8.66 M -137% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$30.4 M -$11.3 M -$7.26 M -182% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$23.1 M -$5.5 M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$7.35 M -$5.65 M -332% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$6.3 M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$3.99 M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q3 2014 -$1.7 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.